Plunkett Research Online: Anchiano Therapeutics Ltd

ANCHIANO THERAPEUTICS LTD (ANCN:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Anchiano Therapeutics Ltd. (formerly BioCancell Ltd.) is a clinical-stage biotechnology company focused on engineering a targeted gene therapy to improve the standard of care for early-stage bladder cancer. Anchiano has discovered and is developing a biologic agent, inodiftagene, as a new treatment.....



Anchiano Therapeutics Ltd
Ticker: ANCN
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 972-2-548-6555
Fax: 972-2-548-6550
Address: 1/3 High-Tech Village, Givat Ram
Edmond J. Safra Campus, PO Box 39264
Jerusalem, 9139102 Israel

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals Development & Manufacturing
ContactsDescription

Frank HaluskaCEO/Pres.
Jonathan BurginCFO
See More
Anchiano Therapeutics Ltd. (formerly BioCancell Ltd.) is a clinical-stage biotechnology company focused on engineering a targeted gene therapy to improve the standard of care for early-stage bladder cancer. Anchiano has discovered and is developing a biologic agent, inodiftagene, as a new treatment.....See More See More

Auditor: Somekh Chaikin
Legal Advisor:
$USD, In whole numbers,
except marked * or %
20182017201620152014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
inodiftagene
BioCancell Ltd
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: